BE786240Q - Vaccin contre l'hepatite virale et sa preparation - Google Patents

Vaccin contre l'hepatite virale et sa preparation

Info

Publication number
BE786240Q
BE786240Q BE786240A BE786240A BE786240Q BE 786240 Q BE786240 Q BE 786240Q BE 786240 A BE786240 A BE 786240A BE 786240 A BE786240 A BE 786240A BE 786240 Q BE786240 Q BE 786240Q
Authority
BE
Belgium
Prior art keywords
preparation
viral hepatitis
hepatitis vaccine
vaccine
viral
Prior art date
Application number
BE786240A
Other languages
English (en)
French (fr)
Original Assignee
Cancer Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Inst filed Critical Cancer Res Inst
Application granted granted Critical
Publication of BE786240Q publication Critical patent/BE786240Q/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE786240A 1969-10-08 1972-07-13 Vaccin contre l'hepatite virale et sa preparation BE786240Q (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86478869A 1969-10-08 1969-10-08

Publications (1)

Publication Number Publication Date
BE786240Q true BE786240Q (fr) 1972-11-03

Family

ID=25344077

Family Applications (1)

Application Number Title Priority Date Filing Date
BE786240A BE786240Q (fr) 1969-10-08 1972-07-13 Vaccin contre l'hepatite virale et sa preparation

Country Status (7)

Country Link
US (1) US3636191A (de)
JP (1) JPS5019603B1 (de)
BE (1) BE786240Q (de)
DE (1) DE2049515C3 (de)
FR (1) FR2070112B1 (de)
GB (1) GB1282984A (de)
SE (1) SE388542B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507478A1 (fr) * 1981-06-10 1982-12-17 Akad Medyczna Procede pour preparer l'antigene de surface de l'hepatite b pur a partir du plasma humain

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
DE2602892A1 (de) * 1976-01-27 1977-07-28 Community Blood Council Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung
JPS5653397Y2 (de) * 1976-03-11 1981-12-12
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4118477A (en) * 1977-02-14 1978-10-03 Merck & Co., Inc. Hepatitis B antigen
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4741901A (en) * 1981-12-03 1988-05-03 Genentech, Inc. Preparation of polypeptides in vertebrate cell culture
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
CA1341074C (en) 1987-06-22 2000-08-08 Hans A. Thoma Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
JPS63246335A (ja) * 1987-09-17 1988-10-13 メルク　エンド　カムパニー　インコーポレーテツド 肝炎ｂ抗原
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
US11524398B2 (en) 2019-03-19 2022-12-13 Covidien Lp Gear drive mechanisms for surgical instruments

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507478A1 (fr) * 1981-06-10 1982-12-17 Akad Medyczna Procede pour preparer l'antigene de surface de l'hepatite b pur a partir du plasma humain

Also Published As

Publication number Publication date
DE2049515C3 (de) 1980-08-21
GB1282984A (en) 1972-07-26
SE388542B (sv) 1976-10-11
US3636191A (en) 1972-01-18
FR2070112B1 (de) 1974-06-21
DE2049515A1 (de) 1971-04-15
DE2049515B2 (de) 1979-12-20
JPS5019603B1 (de) 1975-07-08
FR2070112A1 (de) 1971-09-10

Similar Documents

Publication Publication Date Title
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
BE805570A (fr) Vaccins et leur preparation
BE753635A (fr) " o-acyl-lysergols et leur preparation
BE841811A (fr) Vaccin contre l'hepatite b
MC894A1 (fr) Benzil-pyrimidines et leur préparations
BE751568A (fr) Amino-oxazolines leurs derives et leur preparation
BE777614A (fr) Colorants oxaziniques basiques et leur preparation
BE751029A (fr) 5'-esters d'ara-cytidine et leur preparation
BE758969A (fr) Alcoyl-adamantanes et leur preparation
BE761438A (fr) Alpha-halo-phenylacetamides et leur preparation
BE767180A (fr) Composes anthraquinoniques et leur preparation
BE754523A (fr) Vaccins
SE380261B (sv) Sett att framstella n-bensoyl-2-alkyl-3-indolyl-ettiksyra och derivat derav
BE760474A (fr) Colorants diazoiques et leur preparation
BE748287A (fr) Colorants anthraquinoniques et leur preparation
BE748286A (fr) Colorants anthraquinoniques et leur preparation
BE771797A (fr) Colorants styryliques et leur preparation
BE757863A (fr) Colorants anthraquinoniques solubles dans l'eau et leur preparation
BE756792A (fr) Poly-organosiloxanes modifies et leur preparation
AU456693B2 (en) Improvements; in virus vaccines
BE745333A (fr) Colorants disazoiques et leur preparation
IL29770A (en) Purification and concentration of animal viruses and preparation of viral vaccines
IL32057A (en) Cultivation of foot and mouth disease virus
BE754021A (fr) Derives d'hydroxyisoquinuclidine et leur preparation
BE759733A (fr) Colorants monoazoiques solubles dans l'eau et leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE INSTITUTE FOR CANCER RESEARCH

Effective date: 19890731